Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-16 Option Award | 2024-01-18 8:00 pm | N/A 2034-01-16 | MiNK Therapeutics Inc. | INKT | van Dijk Marcus Antonius Chief Scientific Officer | 186,078 | $0 | 186,078 (Direct) | View |
| 2023-01-09 Option Award | 2023-01-12 10:48 am | N/A N/A | MiNK Therapeutics Inc. | INKT | van Dijk Marcus Antonius Chief Scientific Officer | 51,628 | $2.32 | 27,363 (Direct) | View |
| 2023-01-09 Tax Withholding | 2023-01-12 10:48 am | N/A N/A | MiNK Therapeutics Inc. | INKT | van Dijk Marcus Antonius Chief Scientific Officer | 24,265 | $2.32 | 27,363 (Direct) | View |
| 2023-01-09 Option Award | 2023-01-11 5:26 pm | N/A 2033-01-09 | MiNK Therapeutics Inc. | INKT | van Dijk Marcus Antonius Chief Scientific Officer | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-01-21 Option Award | 2022-01-25 5:19 pm | N/A 2032-01-21 | MiNK Therapeutics Inc. | INKT | van Dijk Marcus Antonius Chief Technology Officer | 62,500 | $0 | 62,500 (Direct) | View |
Ownership | 2021-10-20 6:52 pm | N/A 2028-11-08 | MiNK Therapeutics Inc. | INKT | van Dijk Marcus Antonius Chief Technology Officer | 0 | $0 | 236,554 (Direct) | View |